Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Spark Capital Advisors(India) Private Limited
$46.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Glenmark Pharmaceuticals Ltd Gets USFDA Nod For Generic Desoximetasone Ointment-Business Standard


Monday, 23 Sep 2013 07:30am EDT 

Business Standard reported that Glenmark Pharmaceuticals Ltd has received final approval from the US health regulator for its generic Desoximetasone Ointment and will commence the shipping of the product immediately. Glenmark Generics Inc USA, the subsidiary of Glenmark Generics Ltd has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (USFDA) for Desoximetasone Ointment USP, 0.25%. 

Company Quote

704.2
-1.65 -0.23%
22 Oct 2014